Last 7 days
0.3%
Last 30 days
-4.8%
Last 90 days
-12.6%
Trailing 12 Months
-6.5%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-08 | ANDERSON KERRII B | sold | -1,057,830 | 211 | -5,000 | - |
2023-08-01 | Wilkinson Peter J | sold (taxes) | -3,631 | 213 | -17.00 | svp, chief accounting officer |
2023-08-01 | Wilkinson Peter J | acquired | - | - | 56.00 | svp, chief accounting officer |
2023-06-29 | van der Vaart Sandra D | sold | -50,880 | 240 | -212 | evp, chief legal officer |
2023-05-19 | Kirchgraber Paul R | sold | -932,707 | 216 | -4,300 | ceo, covance drug development |
2023-05-19 | Kirchgraber Paul R | acquired | 784,793 | 182 | 4,300 | ceo, covance drug development |
2023-05-18 | Schroeder Mark S | acquired | 195,900 | 130 | 1,500 | evp, pres diagnostics & coo |
2023-05-18 | Schroeder Mark S | sold | -325,155 | 216 | -1,500 | evp, pres diagnostics & coo |
2023-03-31 | Schroeder Mark S | sold | -879,982 | 225 | -3,897 | evp, president-diagnostics lab |
2023-03-30 | Wilkinson Peter J | acquired | - | - | 1,798 | svp, chief accounting officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-20 | Mondrian Investment Partners LTD | added | 5.92 | 16,211,300 | 158,182,000 | 3.16% |
2023-09-18 | WASHINGTON CAPITAL MANAGEMENT, INC | added | 113 | 672,340 | 1,211,480 | 1.03% |
2023-09-12 | Farther Finance Advisors, LLC | added | 31.5 | 22,355 | 80,638 | 0.02% |
2023-09-08 | TUCKER ASSET MANAGEMENT LLC | reduced | -74.19 | -5,181 | 1,931 | -% |
2023-09-07 | JAG CAPITAL MANAGEMENT, LLC | added | 36.7 | 760,562 | 2,497,040 | 0.29% |
2023-09-07 | ST GERMAIN D J CO INC | new | - | 43,439 | 43,439 | -% |
2023-09-05 | Covenant Partners, LLC | unchanged | - | 14,030 | 284,287 | 0.10% |
2023-08-25 | EUBEL BRADY & SUTTMAN ASSET MANAGEMENT INC | added | 2.18 | 1,015,000 | 14,568,000 | 2.01% |
2023-08-24 | Alberta Investment Management Corp | added | 33.68 | 177,080 | 612,978 | 0.01% |
2023-08-23 | Rehmann Capital Advisory Group | reduced | -0.47 | 57,198 | 1,278,620 | 0.12% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 09, 2023 | vanguard group inc | 11.79% | 10,450,115 | SC 13G/A | |
Jan 26, 2023 | blackrock inc. | 13.0% | 11,474,507 | SC 13G/A | |
Jan 20, 2023 | blackrock inc. | 13.0% | 11,474,507 | SC 13G/A | |
Mar 09, 2022 | blackrock inc. | 10.4% | 9,706,541 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 11.24% | 10,753,065 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 8.6% | 8,274,411 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 10.68% | 10,405,602 | SC 13G/A | |
Jan 29, 2021 | blackrock inc. | 8.0% | 7,832,565 | SC 13G/A | |
Feb 12, 2020 | vanguard group inc | 11.21% | 10,891,852 | SC 13G/A | |
Feb 05, 2020 | blackrock inc. | 9.1% | 8,855,703 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 14, 2023 | 8-K | Current Report | |
Sep 11, 2023 | 8-K | Current Report | |
Aug 10, 2023 | 4 | Insider Trading | |
Aug 09, 2023 | 8-K | Current Report | |
Aug 08, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 04, 2023 | 10-Q | Quarterly Report | |
Aug 03, 2023 | 4 | Insider Trading | |
Jul 31, 2023 | 8-K | Current Report | |
Jul 27, 2023 | 8-K | Current Report | |
Jul 24, 2023 | SC 13D/A | 13D - Major Acquisition |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
HCA | 69.4B | 61.9B | -7.50% | 26.00% | 12.02 | 1.12 | 3.02% | -11.37% |
LH | 18.2B | 14.1B | -4.84% | -6.54% | 21.91 | 1.29 | -5.68% | -58.27% |
DGX | 14.0B | 9.5B | -5.93% | 1.08% | 17.63 | 1.48 | -10.34% | -46.50% |
MID-CAP | ||||||||
DVA | 9.4B | 11.7B | 1.41% | 13.03% | 20.16 | 0.8 | 0.96% | -43.93% |
CHE | 7.8B | 2.2B | 2.63% | 10.06% | 34.39 | 3.56 | 2.13% | -18.31% |
THC | 7.1B | 19.9B | -2.85% | 22.41% | 6.26 | 0.36 | 3.98% | -22.32% |
EHC | 7.0B | 4.6B | -0.06% | 39.84% | 22.16 | 1.52 | 9.56% | -4.24% |
ACHC | 6.5B | 2.8B | -6.23% | -13.68% | 23.9 | 2.33 | 13.40% | -2.45% |
PGNY | 3.3B | 957.5M | -8.01% | -15.46% | 66.71 | 3.43 | 55.17% | 8.05% |
GH | 3.2B | 510.2M | -27.36% | -50.73% | -6.35 | 6.32 | 25.00% | 4.56% |
SMALL-CAP | ||||||||
RDNT | 1.9B | 1.5B | -8.12% | 43.46% | -147.16 | 1.24 | 12.20% | -155.34% |
XGN | 39.3M | 52.9M | -8.98% | -46.92% | -1.12 | 0.74 | 23.27% | 10.26% |
AMS | 15.5M | 20.4M | -11.49% | -6.52% | 28.15 | 0.76 | 9.05% | -51.79% |
OTRK | 4.7M | 10.8M | -41.82% | -73.41% | -0.13 | 0.43 | -71.53% | 35.85% |
7.6%
6.1%
3.8%
4.1%
66.5%
37.7%
19.2%
Y-axis is the maximum loss one would have experienced if Laboratory Corporation of America Holdin was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 0.8% | 14,092 | 13,981 | 14,877 | 14,485 | 14,941 | 15,859 | 16,121 | 16,555 | 16,388 | 15,316 | 13,979 | 12,442 | 11,475 | 11,587 | 11,555 | 11,389 | 11,292 | 11,276 | 11,333 | 11,291 | 11,081 |
Cost Of Revenue | 2.1% | 10,246 | 10,035 | 10,492 | 9,875 | 10,005 | 10,601 | 10,497 | 10,400 | 10,060 | 9,492 | 9,026 | 8,574 | 8,348 | 8,397 | 8,302 | 8,185 | 8,115 | 8,089 | 8,157 | 8,070 | 7,865 |
Gross Profit | -2.5% | 3,846 | 3,947 | 4,385 | 4,610 | 4,936 | 5,258 | 5,624 | 6,154 | 6,328 | 5,824 | 4,953 | 3,869 | 3,127 | 3,191 | 3,253 | 3,204 | 3,177 | 3,187 | 3,176 | 3,221 | 3,215 |
S&GA Expenses | 3.6% | 2,106 | 2,033 | 1,997 | 1,950 | 1,960 | 1,986 | 1,952 | 1,926 | 1,826 | 1,764 | 1,729 | 1,625 | 1,607 | 1,626 | 1,625 | 1,608 | 1,588 | 1,568 | 1,571 | 1,591 | 1,591 |
Interest Expenses | 4.0% | 196 | 189 | 180 | 174 | 170 | 206 | 212 | 217 | 227 | 201 | 207 | 224 | 233 | 239 | 241 | 235 | 233 | 237 | 244 | 254 | 254 |
Net Income | -17.0% | 831 | 1,000 | 1,279 | 1,756 | 1,991 | 2,099 | 2,377 | 2,763 | 2,879 | 2,643 | 1,556 | 845 | -175 | -216 | 286 | 217 | 853 | 896 | 884 | 1,414 | 1,266 |
Net Income Margin | -100.0% | - | 0.07* | 0.09* | 0.12* | 0.13* | 0.13* | 0.15* | 0.17* | 0.18* | 0.17* | 0.11* | 0.07* | 0.03* | 0.03* | 0.07* | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 1,263 | 1,474 | 1,486 | 1,865 | 1,704 | 2,777 | 2,777 | 2,836 | 2,719 | 1,754 | 1,520 | 1,174 | 1,070 | 1,045 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -12.3% | 17,719 | 20,200 | 20,155 | 19,826 | 20,403 | 20,728 | 20,385 | 20,867 | 20,417 | 20,417 | 20,072 | 18,740 | 17,849 | 17,298 | 18,046 | 17,848 | 17,744 | 16,971 | 16,185 | 16,661 | 16,505 |
Current Assets | 9.1% | 5,121 | 4,695 | 4,625 | 4,372 | 5,031 | 5,230 | 5,331 | 6,021 | 5,694 | 5,638 | 5,125 | 4,086 | 3,413 | 2,891 | 2,981 | 2,988 | 2,849 | 2,885 | 2,835 | 3,274 | 3,021 |
Cash Equivalents | 390.1% | 1,931 | 394 | 321 | 410 | 978 | 1,234 | 1,473 | 2,037 | 1,963 | 1,891 | 1,321 | 667 | 557 | 324 | 338 | 361 | 265 | 349 | 427 | 893 | 893 |
Inventory | 1.3% | 488 | 481 | 471 | 468 | 436 | 441 | 401 | 411 | 421 | 428 | 423 | 393 | 342 | 254 | 245 | 235 | 220 | 234 | 237 | 233 | 231 |
Net PPE | -6.2% | 2,762 | 2,944 | 2,794 | 2,885 | 2,870 | 2,808 | 2,815 | 2,692 | 2,702 | 2,697 | 2,730 | 2,609 | 2,628 | 2,610 | 2,637 | 2,463 | 2,544 | 2,458 | 1,740 | 1,734 | 1,711 |
Goodwill | -23.8% | 6,182 | 8,116 | 6,124 | 8,218 | 8,114 | 8,166 | 7,959 | 7,907 | 7,745 | 7,721 | 7,752 | 7,614 | 7,423 | 7,389 | 7,865 | 7,815 | 7,844 | 7,386 | 7,360 | 7,363 | 7,423 |
Liabilities | -9.4% | 8,914 | 9,839 | 10,040 | 9,715 | 9,982 | 9,987 | 10,091 | 10,321 | 10,151 | 10,375 | 10,614 | 10,481 | 10,477 | 10,260 | 10,459 | 10,597 | 10,580 | 9,840 | 9,195 | 9,393 | 9,447 |
Current Liabilities | -24.3% | 2,183 | 2,886 | 3,079 | 2,522 | 2,643 | 2,642 | 2,783 | 2,888 | 2,667 | 3,369 | 3,079 | 3,010 | 3,034 | 2,458 | 2,656 | 2,555 | 2,496 | 2,527 | 1,879 | 2,106 | 2,122 |
LT Debt, Non Current | -0.2% | 5,042 | 5,052 | 5,039 | 5,334 | 5,360 | 5,383 | 5,417 | 5,417 | 5,423 | 4,921 | 5,419 | 5,417 | 5,417 | 5,790 | 5,790 | 6,101 | 6,135 | 5,496 | 5,991 | 6,045 | 6,039 |
Shareholder's Equity | -15.1% | 8,785 | 10,342 | 10,097 | 10,092 | 10,401 | 10,721 | 10,273 | 10,601 | 10,322 | 10,098 | 9,437 | 8,239 | 7,353 | 7,020 | 7,644 | 7,020 | 7,144 | 7,111 | 7,048 | 7,248 | 7,038 |
Retained Earnings | -17.6% | 8,836 | 10,730 | 10,582 | 10,845 | 10,898 | 10,948 | 10,457 | 10,787 | 10,417 | 10,172 | 9,479 | 8,464 | 7,761 | 7,529 | 7,981 | 7,677 | 7,456 | 7,265 | 7,157 | 6,922 | 6,603 |
Additional Paid-In Capital | 97.9% | 94.00 | 48.00 | - | - | - | 29.00 | - | - | - | 67.00 | 110 | 81.00 | 32.00 | - | 27.00 | 48.00 | 91.00 | 1,401 | 1,451 | 1,828 | 1,935 |
Shares Outstanding | -13.9% | 89.00 | 103 | 88.00 | 104 | 106 | 111 | 108 | 111 | 112 | 114 | 113 | 113 | 113 | 113 | 113 | 113 | 114 | 115 | 115 | 118 | 119 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -12.8% | 1,500 | 1,721 | 1,956 | 2,000 | 2,393 | 2,308 | 3,110 | 3,187 | 3,206 | 3,089 | 2,135 | 1,931 | 1,600 | 1,483 | 1,445 | 1,361 | 1,158 | 1,292 | 1,305 | 1,384 | 1,529 |
Share Based Compensation | 0.8% | 148 | 147 | 144 | 156 | 165 | 163 | 154 | 138 | 107 | 123 | 112 | 108 | 113 | 99.00 | 107 | 104 | 92.00 | 91.00 | 92.00 | 95.00 | 109 |
Cashflow From Investing | -0.9% | -1,189 | -1,178 | -1,652 | -1,633 | -1,477 | -1,325 | -884 | -758 | -636 | -669 | -643 | -667 | -621 | -1,249 | -1,283 | -1,277 | -488 | 141 | 207 | 175 | -1,688 |
Cashflow From Financing | 148.3% | 660 | -1,365 | -1,322 | -1,958 | -1,787 | -1,633 | -2,065 | -1,058 | -1,173 | -864 | -517 | -965 | -684 | -252 | -252 | -606 | -620 | -1,428 | -1,389 | -1,067 | 80.00 |
Dividend Payments | -1.1% | 259 | 261 | - | 175 | 89.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buy Backs | - | 2,200 | - | 1,100 | 1,600 | 933 | 800 | - | 669 | 437 | 137 | 100 | 219 | 250 | 450 | 450 | 800 | 850 | 725 | 700 | 340 | 232 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Millions | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Net restructuring and other special charges | $ 15.8 | $ 31.5 | $ 23.3 | $ 35.0 |
Operating Income (Loss) | 266.3 | 428.8 | 596.1 | 1,034.0 |
Interest Expense | 49.8 | 42.3 | 100.5 | 84.4 |
Equity method income, net | 0.9 | 1.4 | (1.2) | 4.8 |
Investment income | 4.5 | 1.7 | 6.7 | 2.5 |
Other, net | (16.9) | (29.5) | (23.8) | (45.2) |
Earnings before income taxes | 205.0 | 360.1 | 477.3 | 911.7 |
Provision for income taxes | 49.8 | 92.1 | 113.7 | 222.6 |
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | 155.2 | 268.0 | 363.6 | 689.1 |
Net earnings | 189.1 | 358.9 | 402.4 | 851.0 |
Net Income (Loss) Attributable to Noncontrolling Interest | 0.2 | 0.3 | 0.6 | 0.8 |
Net Income (Loss) Attributable to Parent | $ 188.9 | $ 358.6 | $ 401.8 | $ 850.2 |
Income (Loss) from Continuing Operations, Per Basic Share | $ 1.75 | $ 2.90 | $ 4.10 | $ 7.43 |
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share | 0.38 | 0.99 | 0.43 | 1.74 |
Basic earnings per common share (in dollars per share) | 2.13 | 3.89 | 4.53 | 9.17 |
Diluted earnings per common share (in dollars per share) | $ 2.12 | $ 3.87 | $ 4.51 | $ 9.11 |
Revenues | $ 3,033.7 | $ 2,923.0 | $ 6,071.5 | $ 6,067.5 |
Cost of Revenue | 2,191.5 | 1,980.5 | 4,379.2 | 4,042.9 |
Gross Profit | 842.2 | 942.5 | 1,692.3 | 2,024.6 |
Selling, general and administrative expenses | 505.8 | 432.4 | 963.0 | 854.4 |
Amortization of intangibles and other assets | 51.5 | 49.8 | 104.9 | 100.0 |
Asset Impairment Charges | 2.8 | 0.0 | 5.0 | 1.2 |
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $ 33.9 | $ 90.9 | $ 38.8 | $ 161.9 |
Income (Loss) from Continuing Operations, Per Diluted Share | $ 1.74 | $ 2.89 | $ 4.08 | $ 7.38 |
Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share | $ 0.38 | $ 0.98 | $ 0.43 | $ 1.73 |
Revenues | $ 3,033.7 | $ 2,923.0 | $ 6,071.5 | $ 6,067.5 |
Cost of Revenue | 2,191.5 | 1,980.5 | 4,379.2 | 4,042.9 |
Gross Profit | 842.2 | 942.5 | 1,692.3 | 2,024.6 |
Selling, general and administrative expenses | 505.8 | 432.4 | 963.0 | 854.4 |
Amortization of intangibles and other assets | 51.5 | 49.8 | 104.9 | 100.0 |
Asset Impairment Charges | 2.8 | 0.0 | 5.0 | 1.2 |
Net restructuring and other special charges | 15.8 | 31.5 | 23.3 | 35.0 |
Operating Income (Loss) | 266.3 | 428.8 | 596.1 | 1,034.0 |
Other income (expenses): | ||||
Interest expense | (49.8) | (42.3) | (100.5) | (84.4) |
Equity method income, net | 0.9 | 1.4 | (1.2) | 4.8 |
Investment income | 4.5 | 1.7 | 6.7 | 2.5 |
Other, net | (16.9) | (29.5) | (23.8) | (45.2) |
Earnings before income taxes | 205.0 | 360.1 | 477.3 | 911.7 |
Provision for income taxes | 49.8 | 92.1 | 113.7 | 222.6 |
Net earnings | 189.1 | 358.9 | 402.4 | 851.0 |
Less: Net earnings attributable to the noncontrolling interest | (0.2) | (0.3) | (0.6) | (0.8) |
Net earnings attributable to Laboratory Corporation of America Holdings | $ 188.9 | $ 358.6 | $ 401.8 | $ 850.2 |
Basic earnings per common share (in dollars per share) | $ 2.13 | $ 3.89 | $ 4.53 | $ 9.17 |
Diluted earnings per common share (in dollars per share) | $ 2.12 | $ 3.87 | $ 4.51 | $ 9.11 |
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) | 3 Months Ended | 6 Months Ended | |
---|---|---|---|
Jun. 30, 2023 USD ($) | Jun. 30, 2023 USD ($) | Dec. 31, 2022 USD ($) | |
Current assets: | |||
Accounts Receivable, after Allowance for Credit Loss, Current | $ 1,904,800,000 | $ 1,904,800,000 | $ 1,785,500,000 |
Unbilled Contracts Receivable | 137,800,000 | 137,800,000 | 211,800,000 |
Supplies inventories | 487,800,000 | 487,800,000 | 470,600,000 |
Prepaid expenses and other | 659,900,000 | 659,900,000 | 610,400,000 |
Disposal Group, Including Discontinued Operation, Assets, Current | 0 | 0 | 1,226,100,000 |
Total current assets | 5,120,900,000 | 5,120,900,000 | 4,625,000,000 |
Property, plant and equipment, net | 2,762,100,000 | 2,762,100,000 | 2,794,100,000 |
Goodwill, net | 6,182,200,000 | 6,182,200,000 | 6,123,700,000 |
Intangible Assets, Net (Excluding Goodwill) | 3,154,100,000 | 3,154,100,000 | 3,123,600,000 |
Joint venture partnerships and equity method investments | 67,200,000 | 67,200,000 | 65,700,000 |
Deferred Income Taxes and Other Assets, Current | 6,400,000 | 6,400,000 | 6,400,000 |
Other assets, net | 425,800,000 | 425,800,000 | 378,400,000 |
Disposal Group, Including Discontinued Operation, Assets, Noncurrent | 0 | 0 | 3,038,200,000 |
Total assets | 17,718,700,000 | 17,718,700,000 | 20,155,100,000 |
Liabilities, Current [Abstract] | |||
Accounts Payable, Current | 713,100,000 | 713,100,000 | 852,200,000 |
Accrued Liabilities, Current | 657,800,000 | 657,800,000 | 787,000,000.0 |
Deferred Revenue, Current | 349,700,000 | 349,700,000 | 310,600,000 |
Operating Lease, Liability, Current | 154,800,000 | 154,800,000 | 163,800,000 |
Finance Lease, Liability, Current | 6,500,000 | 6,500,000 | 6,000,000.0 |
Current debt excluding finance lease liability | 301,400,000 | 301,400,000 | 301,300,000 |
Long-term debt, less current portion | 2,183,300,000 | 2,183,300,000 | 3,078,500,000 |
Long-term Debt, Excluding Current Maturities | 5,042,400,000 | 5,042,400,000 | 5,038,800,000 |
Commitments and contingent liabilities | 418,500,000 | 418,500,000 | 401,100,000 |
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent | 0 | 0 | 241,300,000 |
Operating Lease, Liability, Noncurrent | 623,500,000 | 623,500,000 | 652,900,000 |
Finance Lease, Liability, Noncurrent | 81,700,000 | 81,700,000 | 83,600,000 |
Deferred income taxes and other tax liabilities | 564,500,000 | 564,500,000 | 543,400,000 |
Noncontrolling interest | 8,913,900,000 | 8,913,900,000 | 10,039,600,000 |
Shareholders' equity: | |||
Common stock, 92.8 and 93.5 shares outstanding at March 31, 2013 and December 31, 2012, respectively | 19,800,000 | 19,800,000 | 18,900,000 |
Additional paid-in capital | 94,400,000 | 94,400,000 | 0 |
Retained earnings | 8,100,000 | 8,100,000 | 8,100,000 |
Accumulated other comprehensive income | (8,836,200,000) | (8,836,200,000) | (10,581,700,000) |
Total liabilities and shareholders' equity | (153,700,000) | (153,700,000) | (493,200,000) |
Stockholders' Equity Attributable to Parent | 8,785,000,000 | 8,785,000,000 | 10,096,600,000 |
Liabilities and Equity | 17,718,700,000 | 17,718,700,000 | 20,155,100,000 |
Net earnings | 189,100,000 | 402,400,000 | |
Cash and cash equivalents | 1,930,600,000 | 1,930,600,000 | 320,600,000 |
Disposal Group, Including Discontinued Operation, Liabilities, Current | $ 0 | $ 0 | $ 657,600,000 |